MF
EDIT icon

Manchester Financial’s Editas Medicine EDIT Stock Holding History

Manchester Financial’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$8K – 237
2021
Q1 		$8K Hold
200
– – ﹤0.01% 462
2020
Q4 		$14K Hold
200
– – 0.01% 320
2020
Q3 		$6K Hold
200
– – ﹤0.01% 367
2020
Q2 		$6K Hold
200
– – ﹤0.01% 352
2020
Q1 		$4K Hold
200
– – ﹤0.01% 370
2019
Q4 		$6K Buy
+200
New +$5K ﹤0.01% 397

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Manchester Financial's EDIT Position: Q2 2021 in Review

Manchester Financial sold out of Editas Medicine (EDIT) in Q2 2021, closing a stake of 200 shares — an estimated $8K sold.

Manchester Financial first reported a position in EDIT in Q4 2019 and held it in 6 quarters. The position peaked at $14K in Q4 2020. 313 funds tracked by Wall St. Rank hold EDIT as of Q2 2021.

  • Manchester Financial reported no remaining Editas Medicine position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 200 Editas Medicine shares in Q2 2021, an estimated $8K.
  • Manchester Financial first reported a position in Editas Medicine in Q4 2019 and held it in 6 quarters.
  • Manchester Financial's Editas Medicine position peaked at $14K in Q4 2020.
  • 313 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.